A Phase 3B, Multicenter, Randomized, Double-Masked, Para

  • Bothun, Erick D (PI)

Project: Research project

Project Details

Description

A Phase 3B, Multicenter, Randomized, Double-Masked, Parallel-Group, Active-Controlled Study of the Safety and Efficacy of Difluprednate Ophthalmic Emulsion, 0.05% (Durezol) 4 Times Daily (QID) and Prednisolone Acetate Ophthalmic Suspension, 1.0% (Pred Fo
StatusFinished
Effective start/end date7/1/1012/31/11

Funding

  • ALCON LABORATORIES, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.